Malignant lymphoma with peripheral neuropathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:207046
Who is this for?
Show terms as
8Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Malignant lymphoma with peripheral neuropathy is a rare condition in which a type of blood cancer called lymphoma occurs together with damage to the peripheral nerves (the nerves outside the brain and spinal cord). Lymphoma is a cancer that starts in white blood cells called lymphocytes, which are part of the immune system. In this condition, the lymphoma either directly damages the peripheral nerves or triggers the immune system to attack them. This nerve damage is called peripheral neuropathy and can cause numbness, tingling, pain, or weakness in the hands and feet. The peripheral neuropathy may appear before, during, or after the lymphoma is diagnosed. Sometimes the nerve symptoms are the first clue that a lymphoma is present. The neuropathy can result from the tumor pressing on or invading nerves, from substances produced by the cancer cells, or from the body's immune response mistakenly attacking its own nerve tissue (a paraneoplastic process). In some cases, certain lymphoma treatments such as chemotherapy can also contribute to nerve damage. Treatment focuses on addressing both the underlying lymphoma and the nerve symptoms. Lymphoma treatment may include chemotherapy, immunotherapy, radiation therapy, or stem cell transplant depending on the type and stage. Managing the neuropathy often involves pain medications, physical therapy, and supportive care. Early diagnosis and treatment of the lymphoma can sometimes improve or stabilize the neuropathy, though nerve damage may not always be fully reversible.

Key symptoms:

Numbness or tingling in hands and feetBurning or shooting pain in the limbsMuscle weakness in arms or legsDifficulty walking or balance problemsSwollen lymph nodesUnexplained weight lossNight sweatsPersistent fatigueFever without infectionLoss of sensation in fingers or toesDifficulty gripping objectsMuscle wastingLoss of reflexes

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Mar 2026TAFINLAR: New indication approved
FDAcompleted
Mar 2026TAFINLAR: New indication approved
FDAcompleted
Feb 2026Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia

The Hong Kong Polytechnic University — NA

TrialNOT YET RECRUITING
Apr 2025TAFINLAR: New indication approved
FDAcompleted
Apr 2025TAFINLAR: New indication approved
FDAcompleted
Mar 2025TAFINLAR: New indication approved
FDAcompleted
Mar 2025TAFINLAR: New indication approved
FDAcompleted
Mar 2025TAFINLAR: New indication approved
FDAcompleted
Mar 2025TAFINLAR: New indication approved
FDAcompleted
Jan 2025TAFINLAR: New indication approved
FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Malignant lymphoma with peripheral neuropathy.

View clinical trials →

No actively recruiting trials found for Malignant lymphoma with peripheral neuropathy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Malignant lymphoma with peripheral neuropathy community →

Specialists

8 foundView all specialists →
JM
Julia L. Glade-Bender, MD
Specialist
PI on 2 active trials
TP
Timothy Cripe, MD, PhD
COLUMBUS, OH
Specialist
PI on 1 active trial
RM
Rosandra N Kaplan, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 4 active trials
MM
Margaret MacMillan
Minneapolis, Minnesota
Specialist

Rare Disease Specialist

PI on 1 active trial12 Malignant lymphoma with peripheral neuropathy publications
JD
Jin Li, Doctor
Specialist
PI on 1 active trial
KH
Ka Yan Ho
Specialist
PI on 1 active trial32 Malignant lymphoma with peripheral neuropathy publications
LM
Lynn Tanner, MPT
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources

TAFINLAR

Novartis Pharmaceuticals Corp.

TAFINLAR Patient Support (Novartis Patient Assistance)

Patient Assistance
Manufacturer Program
Accepting applications

Travel Grants

No travel grants are currently matched to Malignant lymphoma with peripheral neuropathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Malignant lymphoma with peripheral neuropathyForum →

No community posts yet. Be the first to share your experience with Malignant lymphoma with peripheral neuropathy.

Start the conversation →

Latest news about Malignant lymphoma with peripheral neuropathy

Disease timeline:

New recruiting trial: Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia

A new clinical trial is recruiting patients for Malignant lymphoma with peripheral neuropathy

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What type and stage of lymphoma do I have, and how does it relate to my nerve symptoms?,Is my peripheral neuropathy caused directly by the lymphoma, by my immune system, or by treatment?,Which chemotherapy drugs are safest for me given my neuropathy, and can any be avoided?,What treatments are available to manage my nerve pain and weakness?,Is the nerve damage likely to improve with lymphoma treatment, or could it be permanent?,Should I see a neurologist in addition to my oncologist?,What rehabilitation services or physical therapy would help me maintain function?

Common questions about Malignant lymphoma with peripheral neuropathy

What is Malignant lymphoma with peripheral neuropathy?

Malignant lymphoma with peripheral neuropathy is a rare condition in which a type of blood cancer called lymphoma occurs together with damage to the peripheral nerves (the nerves outside the brain and spinal cord). Lymphoma is a cancer that starts in white blood cells called lymphocytes, which are part of the immune system. In this condition, the lymphoma either directly damages the peripheral nerves or triggers the immune system to attack them. This nerve damage is called peripheral neuropathy and can cause numbness, tingling, pain, or weakness in the hands and feet. The peripheral neuropath

How is Malignant lymphoma with peripheral neuropathy inherited?

Malignant lymphoma with peripheral neuropathy follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Malignant lymphoma with peripheral neuropathy typically begin?

Typical onset of Malignant lymphoma with peripheral neuropathy is adult. Age of onset can vary across affected individuals.

Which specialists treat Malignant lymphoma with peripheral neuropathy?

8 specialists and care centers treating Malignant lymphoma with peripheral neuropathy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Malignant lymphoma with peripheral neuropathy?

1 patient support program are currently tracked on UniteRare for Malignant lymphoma with peripheral neuropathy. See the treatments and support programs sections for copay assistance, eligibility, and contact details.